Boston Scientific Corporation ( BSX) - Stock Earnings
BSX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
BSX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 668.0 million USD | 5.3 billion USD |
| 2026Q1 | 1.3 billion USD | 5.2 billion USD |
| 2026Q2 | 907.0 million USD | 5.4 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BSX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.6 billion USD | 14.2 billion USD |
| 2024 | 1.9 billion USD | 16.7 billion USD |
| 2025 | 2.9 billion USD | 20.1 billion USD |
| 2026 Est. | — | — |
BSX
Price: $42.73
Earnings Per Share: 2.47 USD
P/E Ratio: 19.61
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 13.0 million
Ebitda: 425.0 millionMarket Capitalization: 63.0 billion